ERT, Science 37 forge virtual trial data partnership

By Jenni Spinner contact

- Last updated on GMT

(elenlabs/iStock via Getty Images Plus)
(elenlabs/iStock via Getty Images Plus)

Related tags: Ert, Decentralized trials, data management, Clinical trials

The companies will work together on solutions designed to enable sponsors to improve imaging, respiratory and cardiac safety data on decentralized trials.

Clinical endpoint data collection specialists ERT and Science 37, a company offering decentralized clinical trial technology, will work together to incorporate ERT’s Cardiac Safety, Respiratory and Imaging solutions into Science 37’s decentralized trial offerings. According to the companies, the combination of the two technologies holds the potential to significantly boost data quality while simultaneously easing burdens placed on patient participants.

Regarding traditional clinical trial models, patients may be asked to travel across long distances to get to a site. This can create inconvenience (especially if the patient is faced with mobility challenges), and increase risk via exposure to COVID-19 and other potentially deadly pathogens.

With a decentralized or virtual trial, patients are able to participate in trials from their homes, which can greatly reduce or eliminate many obstacles associated with travel to a brick-and-mortar research site. Both approaches call for the same level of data integrity and endpoint technologies.

The ERT and Science 37 technology collaboration reportedly enables sponsors to capture the same high-quality data in a virtual model as it would in a traditional model, while at the same time lowering patient burden, minimizing patient risk and enabling study continuity.

Jim Corrigan, CEO of ERT, said that the pandemic has created a number of obstacles for trial teams to overcome.

Given the challenges caused by COVID-19, trial sponsors need effective virtual trial solutions that enable patients to participate safely, without jeopardizing data quality​,” he said. “We’re pleased to partner with Science 37 and to expand the use of our Respiratory, Cardiac Safety and Imaging solutions to support virtual trials throughout the pandemic and beyond​.”

During home and telemedicine visits, Science 37 plans to use use ERT’s remote respiratory and cardiac safety data collection solutions. Additionally, Science 37 will leverage ERT’s Imaging services through a local-care network, with the goal of limiting patient travel through use of medical imaging services that are closer to home.

We are delighted to partner with ERT and to work together in bringing these best-in-class offerings to patients and sponsors​,” said David Coman, CEO of Science 37. “As we make virtual trials the new reality, this partnership enables us to reduce patient burden and provide the high-quality data trial sponsors require as they evaluate the safety and efficacy of new medical treatments​.”

Related news

Show more

Related products

show more

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us

Products

View more

Webinars